|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Goodwill | |||||||||
| Other intangible assets | |||||||||
| Rights of use | |||||||||
| Property, plant and equipment | |||||||||
| Investment in equity-accounted investees | |||||||||
| Non-current financial assets | |||||||||
| Non-current financial assets measured at fair value | |||||||||
| Non-current financial assets at amortized cost | |||||||||
| Total non-current financial assets | |||||||||
| Other non-current assets | |||||||||
| Other non-current contract assets | |||||||||
| Deferred tax assets | |||||||||
| Total non-current assets | |||||||||
| Current assets | |||||||||
| Non-current assets held for sale | |||||||||
| Inventories | |||||||||
| Current contract assets | |||||||||
| Trade and other receivables | |||||||||
| Trade receivables | |||||||||
| Other receivables | |||||||||
| Current income tax assets | |||||||||
| Trade and other receivables | |||||||||
| Other current financial assets | |||||||||
| Current financial assets measured at fair value | |||||||||
| Current financial assets at amortized cost | |||||||||
| Total current financial assets | |||||||||
| Other current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Total current assets | |||||||||
| Total assets | |||||||||
| Equity and liabilities | |||||||||
| Share capital | |||||||||
| Share premium | |||||||||
| Reserves | |||||||||
| Interim dividend | |||||||||
| Treasury stock | |||||||||
| Profit for the year attributable to the Parent | |||||||||
| Total shareholder's equity | |||||||||
| Cash Flow hedges | |||||||||
| Other comprehensive Income | |||||||||
| Other comprehensive income from non-current assets held for sale | |||||||||
| Other comprehensive income from financial instruments valuation | |||||||||
| Translation differences | |||||||||
| Other comprehensive expenses | |||||||||
| Total Other comprehensive expenses | |||||||||
| Equity attributable to the Parent | |||||||||
| Non-controlling interests | |||||||||
| Total equity | |||||||||
| Liabilities | |||||||||
| Non-current liabilities | |||||||||
| Grants | |||||||||
| Provisions | |||||||||
| Non-current financial liabilities | |||||||||
| Other non-current liabilities | |||||||||
| Deferred tax liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Provisions | |||||||||
| Current financial liabilities | |||||||||
| Current other financial liabilities | |||||||||
| Trade and other payables | |||||||||
| Suppliers | |||||||||
| Other payables | |||||||||
| Current income tax liabilities | |||||||||
| Total trade and other payables | |||||||||
| Other current liabilities | |||||||||
| Total current liabilities | |||||||||
| Total liabilities | |||||||||
| Total equity and liabilities | |||||||||
Loading...
